WASHINGTON – The Food and Drug Administration reissued a nationwide alert Friday against the use of IV Flush brand preloaded syringes containing either heparin or sodium chloride because the products have not been approved and may be contaminated.
The FDA first warned consumers and institutions about the syringes on Monday. Since then the agency has been informed of a cluster of infections in patients that may be associated with the heparin flushes.
The syringes, distributed by Pinnacle Medical Supply of Rowlett, Texas, were sold to distributors who redistributed them to hospitals and other medical distributors. The syringe label reads, in part, “IV Flush Dallas, TX.”
Syringes should be returned to IV Flush or the original distributor, the FDA said. Consumers with questions can contact Pinnacle at (972) 463-7389.